InvestorsHub Logo
Followers 65
Posts 2029
Boards Moderated 0
Alias Born 10/31/2017

Re: kabunushi post# 146220

Wednesday, 11/29/2017 7:48:21 AM

Wednesday, November 29, 2017 7:48:21 AM

Post# of 698806
Again, I am very, very long this stock and believe the results will prove positive. Thus, I am in deep and will remain so. Any suggestion by do-know-wrong longs to sell is crazy talk.

Having said that Kab, perhaps the answer to your misunderstanding is that the run up that we recently saw and possibly even a much higher run would have occurred in August or early September if reaching the OS target was announced and transparency over the expected timeline were given. A statement such as "we expect to report results in late Q4" as is expected in this sector may have even driven the price into the $2-3 range by now. And as you know, why this is relevant is that it would have been very hard to grab all those shares for themselves at ridiculously low prices if this had occurred. Who knows, we may have even had a white knight step in and provide serious funding by now. Wouldn't that have been something for long time shareholders to see again, especially with about 20% less dilution in place.

This company has a potential 2019 blockbuster with phase 3 results pending any day and our market cap is less than $100 million. This is so far from the typical valuation for an even somewhat promising biotech that it is beyond laughable AND insider leadership silence is largely to blame.

The way to combat lying bloggers is to be transparent with the truth!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News